Screener
Halozyme Therapeutics HALO Common Stock Shares Issued
Common Stock Shares Issued at other companies
Other financials
Where this comes from
Reported directly by Halozyme Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The source filing: Halozyme Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001159036-26-000104
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Commitments and contingencies (Note 11) | ||
| Stockholders’ equity | ||
| Preferred stock - $0.001 par value; 20,000 shares authorized; no shares issued and outstanding | — | — |
| Common stock - $0.001 par value; 300,000 shares authorized; 114,042 and 117,782 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 114 | 118 |
| Additional paid-in capital | — | 12,002 |
| Accumulated other comprehensive loss | (7,830) | (18,092) |
| Retained earnings | 151,259 | 54,786 |
| Total stockholders’ equity | 143,543 | 48,814 |
Item 1. Financial Statements
FAQ
- What is Halozyme Therapeutics's common stock shares issued?
- Halozyme Therapeutics (HALO) reported common stock shares issued of 114M in Q2 2026.
- How has Halozyme Therapeutics's common stock shares issued changed year-over-year?
- Halozyme Therapeutics's common stock shares issued decreased by 3.0% year-over-year, from 117.6M to 114M.
- What is the long-term trend for Halozyme Therapeutics's common stock shares issued?
- Over 5 years (2020 to 2025), Halozyme Therapeutics's common stock shares issued has grown at a -3.5% compound annual growth rate (CAGR), from 141M to 117.8M.
- What does common stock shares issued mean?
- The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.
Ask your AI about Halozyme Therapeutics's common stock shares issued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude